Use of Genetically Modified (GM) Mosquitoes for Eradication of Mosquito-Borne Diseases

In a bid to control the mosquito borne diseases, first genetically modified mosquitoes have been released in the United States in the state of Florida after a long arduous wait with respect to push back from people and the regulators. The experiment has been launched in the Keys region of Florida that houses Aedes aegypti as 4% of its mosquito population and is capable of transmitting diseases such as Zika, dengue, chikungunya and yellow fever. The idea is to genetically engineer the male Aedes mosquito by making them carry a gene that is passed on to the offspring which kills female progeny in their larval stages1. Since male mosquitoes don’t bite, they will mate with the female wild type mosquito, responsible for biting the host and transmitting the disease, and the male progeny will survive while the females will be killed in the larval stage. The male with thus become carriers and this will lead to elimination of females and eventually the Aedes population. This will eventually lead to the region which is free of diseases such as Zika, dengue, chikungunya and yellow fever. However, the long-term impact of elimination of Aedes aegypti population from the ecosystem, if any, remains to be seen. 

Genetically engineered mosquitoes are an alternative to using insecticides as repeated insecticide use lead to insecticide resistance that can be overcome by use of these genetically engineered mosquitoes. 

The genetically engineered mosquitoes have been developed by Oxitec2, a firm based in Abingdon, UK. The mosquitoes have been previously field-tested in Brazil, where a 95% reduction was seen in dengue-prone environments following just 13 weeks of treatment, as compared to untreated control sites in the same city. Similar experiments have been done in Panama, the Cayman Islands and Malaysia.  

The technology of genetically engineering mosquitoes in such a manner can also have implications in the elimination of other mosquito borne human diseases such as malaria caused by Anopheles, encephalitis and filariasis caused by Culex, leishmania caused by sandfly and sleeping sickness causes by Tsetse fly, among others. The technology also has a potential use in agriculture for elimination of insects that cause harm to crop and cash plants. 

*** 

Sources: 

  1. Waltz E., 2021. First genetically modified mosquitoes released in the United States. Nature. News 03 MAY 2021. DOI: https://doi.org/10.1038/d41586-021-01186-6  
  1. Oxitec Oxford Insect Technologies): a UK-based biotechnology company that develops genetically modified insects  https://www.oxitec.com/  

*** 

Latest

Brain-Computer Interfaces (BCI): Towards Humans’ Merger with AI 

The ongoing clinical trials of Brain-Computer Interfaces (BCIs) such...

Tumour Treating Fields (TTFields) approved for Pancreatic cancer

Cancer cells have electrically charged parts hence are influenced...

Scientific European invites Co-founder

Scientific European (SCIEU) invites you to join as a Co-Founder and investor, with both...

Future Circular Collider (FCC): CERN Council reviews Feasibility Study

The quest for the answers to the open questions (such as, which...

Chernobyl Fungi as Shield Against Cosmic Rays for Deep-Space Missions 

In 1986, the 4th unit of Chernobyl Nuclear Power Plant in Ukraine...

Myopia Control in Children: Essilor Stellest Eyeglass Lenses Authorised  

Myopia (or near-sightedness) in children is a highly prevalent...

Newsletter

Don't miss

Selegiline’s Wide Array of Potential Therapeutic Effects

Selegiline is an irreversible monoamine oxidase (MAO) B inhibitor1....

Extra-Terrestrial: Search for Signatures of Life

Astrobiology suggest that life is abundant in the universe...

First UK Lung Cancer Patient receives mRNA vaccine BNT116  

BNT116 and LungVax are nucleic acid lung cancer vaccine...

Precision Medicine for Cancer, Neural Disorders and Cardiovascular Diseases

New study shows a method to individually distinguish cells...

IGF-1: Trade Off Between Cognitive Function and Cancer Risk

Insulin-like growth factor 1 (IGF-1) is a prominent growth...
SCIEU Team
SCIEU Teamhttps://www.scientificeuropean.co.uk
Scientific European® | SCIEU.com | Significant advances in science. Impact on humankind. Inspiring minds.

Brain-Computer Interfaces (BCI): Towards Humans’ Merger with AI 

The ongoing clinical trials of Brain-Computer Interfaces (BCIs) such as Neuralink’s “Telepathy” implant involve establishing communication links between the brains of participants who have unmet medical needs due...

Tumour Treating Fields (TTFields) approved for Pancreatic cancer

Cancer cells have electrically charged parts hence are influenced by electric fields. Application of alternating electric fields (TTFields) to solid tumours selectively target and...

Scientific European invites Co-founder

Scientific European (SCIEU) invites you to join as a Co-Founder and investor, with both strategic investment and active contribution in shaping its future direction.  Scientific European is an England-based media outlet providing multilingual...